<DOC>
	<DOCNO>NCT01470274</DOCNO>
	<brief_summary>The primary objective establish safety CO-rebreathing method measure total blood plasma volume CAD patient . The working hypothesis CO-rebreathing method safe use coronary artery disease patient cause myocardial ischemia cardiovascular damage .</brief_summary>
	<brief_title>Safety CO-rebreathing Method Stable Coronary Artery Disease COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Stable coronary artery disease Stable COPD Optimal medication Unstable disease comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Blood volume</keyword>
	<keyword>CO-rebreathing</keyword>
	<keyword>COPD</keyword>
	<keyword>CVD</keyword>
</DOC>